GlaucomaMar 15, 2026
Timolol is one of the most established glaucoma medications available, capable of reducing eye pressure by 20 to 30 percent. That kind of performance is why it remains a go-to treatment decades after its introduction. But here's the part most people don't think about: roughly 78% of the timolol you put in your eye gets absorbed systemically. That means a drug you're applying to your eye is effectively acting like a mild oral beta-blocker, reaching your heart, lungs, and brain.
Understanding what timolol actually does, both in your eye and throughout your body, matters if you're using it daily. The choice of formulation, preservative, and combination drug can meaningfully change your experience.
GlaucomaMar 14, 2026
A single drop of a decades-old eye pressure medication, placed in the eye at the start of a migraine, reduced pain within 20 minutes compared to placebo in a randomized crossover trial. That same drug, timolol maleate, is now being rubbed on infant birthmarks and applied nightly for acne. Few medications have quietly spread across so many unrelated conditions with so little public awareness.
Timolol maleate is a non-selective beta-blocker, meaning it blocks both β1 and β2 adrenergic receptors, the signaling pathways that tell your heart to beat faster and your blood vessels to relax. In the eye, that translates to reduced fluid production and lower pressure. On the skin, it appears to constrict blood vessels and tamp down inflammation. That dual personality is what makes it so adaptable.
GlaucomaMar 13, 2026
Latanoprost is one of the rare treatments that has been proven in a large placebo-controlled trial to not just lower eye pressure, but actually slow the loss of vision in glaucoma. Over 24 months, people using latanoprost saw significantly less visual field deterioration compared to placebo. That's the kind of outcome that matters when you're trying to protect your sight for decades.
But there's a catch baked into the classic formulation. The preservative used to keep the drops stable, benzalkonium chloride (BAK), can damage the surface of your eye, worsen dry eye symptoms, and chip away at the comfort that keeps people using their drops consistently. The good news: newer preservative-free versions appear to work just as well without that tradeoff.
MedicationsMar 13, 2026
Dorzolamide has been a reliable workhorse for lowering eye pressure in glaucoma for years. But the more interesting story right now is what researchers are finding it can do beyond the eye: fighting antibiotic-resistant bacteria and taming inflammation through modified versions of its chemical structure. It is still primarily a glaucoma drug, and a good one, but its second life in the lab suggests this molecule has chapters left to write.
For the millions of people actually using dorzolamide today, though, the practical questions are simpler. How well does it work? What does it feel like? And when is it the right choice over other options?
